arrow
返回

Pyoderma gangrenosum

delete2020-10-08
delete155
delete
OA
AI
E
Emanual Maverakis *
A
Angelo Valerio Marzano
S
Stephanie T. Le
J
Jeffrey P. Callen
M
Marie‐Charlotte Brüggen
E
Emmanuella Guenova
J
Joachim Dissemond
K
Kanade Shinkai
S
Sinéad Langan
DOI:10.1038/s41572-020-0213-xdelete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly developing, painful skin ulcers hallmarked by undermined borders and peripheral erythema. Epidemiological studies indicate that the average age of PG onset is in the mid-40s, with an incidence of a few cases per million person-years. PG is often associated with a variety of other immune-mediated diseases, most commonly inflammatory bowel disease and rheumatoid arthritis. The cause of PG is not well understood, but PG is generally considered an autoinflammatory disorder. Studies have focused on the role of T cells, especially at the wound margin; these cells may support the destructive autoinflammatory response by the innate immune system. PG is difficult to diagnose as several differential diagnoses are possible; in addition to clinical examination, laboratory tests of biopsied wound tissue are required for an accurate diagnosis, and new validated diagnostic criteria will facilitate the process. Treatment of PG typically starts with fast-acting immunosuppressive drugs (corticosteroids and/or cyclosporine) to reduce inflammation followed by the addition of more slowly acting immunosuppressive drugs with superior adverse event profiles, including biologics (in particular, anti-tumour necrosis factor (TNF) agents). Appropriate wound care is also essential. Future research should focus on PG-specific outcome measures and PG quality-of-life studies. Pyoderma gangrenosum is a rare, non-infectious, inflammatory skin condition characterized by rapidly developing, painful ulcers. This Primer provides an overview of the epidemiology, pathophysiology, diagnosis and treatment of the disease.
Keyword:
SUPERFICIAL GRANULOMATOUS PYODERMA
NEUTROPHIL CHEMOTACTIC FACTOR
INFLAMMATORY-BOWEL-DISEASE
QUALITY-OF-LIFE
RHEUMATOID-ARTHRITIS
ULCERATIVE-COLITIS
GENE-EXPRESSION
DOUBLE-BLIND
PYOGENIC ARTHRITIS
TNF-ALPHA
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

N
Nature Reviews Disease Primers
IF:
60.6
论文数:
648
被引数:
3.8W

机构

U
university zurich hospital
学者数:
1.2W
论文数: 9.5K
被引数: 7
U
university of california davis
学者数:
3.4W
论文数: 2.6W
被引数: 45
U
University of Lausanne
学者数:
2.5W
论文数: 2.0W
被引数: 3.0W
U
University of Louisville
学者数:
1.3W
论文数: 1.0W
被引数: 1.3W
University of California System 封面图
University of California System
学者数:
37.5W
论文数: 33.7W
被引数: 6.6K
C
centre hospitalier universitaire vaudois (chuv)
学者数:
9.4K
论文数: 7.4K
被引数: 15
U
university of geneva
学者数:
3.6W
论文数: 2.9W
被引数: 35
U
University of Milan
学者数:
5.1W
论文数: 3.9W
被引数: 5.0W
学者 查看更多机构